Previously, for the first time, our group showed that mPRα is a potential prognostic indicator for breast cancer patients,39 and in this study, we showed that high mPRα expression is also a poor prognostic indicator for patients with lung adenocarcinoma. This evidence concerns the gene PAQR7 and breast carcinoma.